Results 51 to 60 of about 42,609 (234)

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.

The Lancet, 2019
BACKGROUND Antivirals are infrequently prescribed in European primary care for influenza-like illness, mostly because of perceived ineffectiveness in real world primary care and because individuals who will especially benefit have not been identified in ...
C. Butler, A. W. van der Velden, E. Bongard, B. Saville, J. Holmes, S. Coenen, J. Cook, N. Francis, R. Lewis, M. Godycki-Cwirko, C. Llor, S. Chlabicz, C. Lionis, B. Seifert, Pär-Daniel Sundvall, Annelies Colliers, R. Aabenhus, L. Bjerrum, Nicolay Jonassen Harbin, M. Lindbæk, Dominik Glinz, H. Bucher, Bernadett Kovács, Ruta Radzeviciene Jurgute, Pia Touboul Lundgren, P. Little, A. Murphy, A. de Sutter, P. Openshaw, Menno D. de Jong, J. Connor, V. Matheeussen, M. Ieven, H. Goossens, T. Verheij   +34 more
semanticscholar   +1 more source

Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug [PDF]

, 2014
BACKGROUND: Dose selection is an important step in pharmacokinetic (PK) studies of hemodialysis patients. We propose a simulation-based dose-selection method for PK studies of hemodialysis patients using a subpharmacological dose of oseltamivir as a ...
Chun-Soo Lim, Dong Ki Kim, Jay Wook Lee, Jung Pyo Lee, Kook-Hwan Oh, Kwang-Hee Shin, Kwon Wook Joo, Kyung-Sang Yu, Myounghee Kim, Sejoong Kim, Yon Su Kim   +10 more
core   +1 more source

Effectiveness of early oseltamivir treatment in children with pandemic 2009 A/H1N1 influenza in the Vilnius University Children Hospital

Acta Medica Lituanica, 2013
Background. Oseltamivir is recommended for treatment of pandemic influenza in children. The therapy should be started as soon as possible, however, data on the effectiveness of such a treatment is rather limited.
Vytautas Usonis, Irena Narkevičiūtė, Vilija Guntaitė   +2 more
doaj   +1 more source

Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. [PDF]

PLoS Pathogens, 2010
The neuraminidase (NA) inhibitor oseltamivir offers an important immediate option for the control of influenza, and its clinical use has increased substantially during the recent H1N1 pandemic.
Susu Duan, David A Boltz, Patrick Seiler, Jiang Li, Karoline Bragstad, Lars P Nielsen, Richard J Webby, Robert G Webster, Elena A Govorkova   +8 more
doaj   +1 more source

Effect of influenza-induced fever on human bioimpedance values [PDF]

, 2015
BACKGROUND AND AIMS: Bioelectrical impedance analysis (BIA) is a widely used technique to assess body composition and nutritional status. While bioelectrical values are affected by diverse variables, there has been little research on validation of BIA ...
Blaser MJ, BUFFA, ROBERTO, CABRAS, STEFANO, Contreras M, Dominguez Bello MG, Hidalgo G, Magris M, MARINI, ELISABETTA, Ortiz V, Sanchez W, Urbaez M   +10 more
core   +1 more source

Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019
BACKGROUND The aim of the present study was to investigate the synergistic effects and interactive mechanisms of Shufeng Jiedu Capsule (SFJDC) combined with oseltamivir in the treatment of acute exacerbation of chronic obstructive pulmonary disease ...
S. Ji, Q. Bai, Xu Wu, Da-wei Zhang, Sheng Wang, Ji-Long Shen, G. Fei   +6 more
semanticscholar   +1 more source

Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.

International Journal of Antimicrobial Agents, 2020
OBJECTIVES The benefit of oseltamivir treatment in patients admitted with influenza virus infection and the design of studies addressing this issue, have been questioned extensively.
G. Groeneveld, S. Marbus, N. Ismail, J. D. de Vries, P. Schneeberger, J. Oosterheert, J. V. van Dissel, M. D. de Boer   +7 more
semanticscholar   +1 more source

Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages

International Journal of Health Geographics, 2010
Background In Spring 2009, a novel reassortant strain of H1N1 influenza A emerged as a lineage distinct from seasonal H1N1. On June 11, the World Heath Organization declared a pandemic - the first since 1968. There are currently two main branches of H1N1
Treseder Travis W, Alexandrov Boyan B, Hardman Jori, Studer Jonathon, Voronkin Igor O, Janies Daniel A, Valson Chandni   +6 more
doaj   +1 more source

Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

Scandinavian Journal of Primary Health Care, 2021
Objective Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely to benefit from oseltamivir ...
Nicolay Jonassen Harbin, Karin Rystedt, Morten Lindbaek, Ruta Radzeviciene, Johan Westin, Ronny Gunnarsson, Christopher C. Butler, Alike W. van der Velden, Theo J. Verheij, Pär-Daniel Sundvall   +9 more
doaj   +1 more source

The impact of co-infection of influenza A virus on the severity of Middle East Respiratory Syndrome Coronavirus [PDF]

, 2017
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Alfaraj, Sarah H., Altwaijri, Talal A., Alzahrani, Nojoom A., Memish, Ziad A.   +4 more
core   +1 more source